JPS5498337A - Anticarcinogenic and/or antimetastatic agent - Google Patents

Anticarcinogenic and/or antimetastatic agent

Info

Publication number
JPS5498337A
JPS5498337A JP46578A JP46578A JPS5498337A JP S5498337 A JPS5498337 A JP S5498337A JP 46578 A JP46578 A JP 46578A JP 46578 A JP46578 A JP 46578A JP S5498337 A JPS5498337 A JP S5498337A
Authority
JP
Japan
Prior art keywords
anticarcinogenic
antimetastatic agent
agent containing
effective component
antimetastatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP46578A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6153325B2 (US20020051482A1-20020502-M00057.png
Inventor
Tadao Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP46578A priority Critical patent/JPS5498337A/ja
Priority to FR7835419A priority patent/FR2413910A1/fr
Priority to ZA00787217A priority patent/ZA787217B/xx
Priority to DE19792900203 priority patent/DE2900203A1/de
Priority to IT47524/79A priority patent/IT1117201B/it
Priority to GB79470A priority patent/GB2012161A/en
Priority to BE0/192776A priority patent/BE873326A/xx
Priority to AU43168/79A priority patent/AU519516B2/en
Publication of JPS5498337A publication Critical patent/JPS5498337A/ja
Priority to US06/436,969 priority patent/US4963559A/en
Publication of JPS6153325B2 publication Critical patent/JPS6153325B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP46578A 1978-01-06 1978-01-06 Anticarcinogenic and/or antimetastatic agent Granted JPS5498337A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP46578A JPS5498337A (en) 1978-01-06 1978-01-06 Anticarcinogenic and/or antimetastatic agent
FR7835419A FR2413910A1 (fr) 1978-01-06 1978-12-15 Medicament anti-cancereux et preventif des metastases cancereuses a base de 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine
ZA00787217A ZA787217B (en) 1978-01-06 1978-12-21 Anti-cancer and cancer metastasis preventing agent
DE19792900203 DE2900203A1 (de) 1978-01-06 1979-01-04 Krebshemmendes und krebsmetastasen verhinderndes arzneimittel
IT47524/79A IT1117201B (it) 1978-01-06 1979-01-04 Medicamento anticanceroso e di prevenzione per metastasi cancerose
GB79470A GB2012161A (en) 1978-01-06 1979-01-05 Anti-cancer and cancer metastasis preventing agent
BE0/192776A BE873326A (fr) 1978-01-06 1979-01-05 Medicament anti-cancereux et preventif des metastases cancereuses
AU43168/79A AU519516B2 (en) 1978-01-06 1979-01-05 Composition containing 5-(2-chlorobenzyl)-4,5,6,7,-tetra- hydro-thieno (3,2-c) pyridine
US06/436,969 US4963559A (en) 1978-01-06 1982-10-27 Method of treating cancer and cancer metastasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP46578A JPS5498337A (en) 1978-01-06 1978-01-06 Anticarcinogenic and/or antimetastatic agent

Publications (2)

Publication Number Publication Date
JPS5498337A true JPS5498337A (en) 1979-08-03
JPS6153325B2 JPS6153325B2 (US20020051482A1-20020502-M00057.png) 1986-11-17

Family

ID=11474538

Family Applications (1)

Application Number Title Priority Date Filing Date
JP46578A Granted JPS5498337A (en) 1978-01-06 1978-01-06 Anticarcinogenic and/or antimetastatic agent

Country Status (9)

Country Link
US (1) US4963559A (US20020051482A1-20020502-M00057.png)
JP (1) JPS5498337A (US20020051482A1-20020502-M00057.png)
AU (1) AU519516B2 (US20020051482A1-20020502-M00057.png)
BE (1) BE873326A (US20020051482A1-20020502-M00057.png)
DE (1) DE2900203A1 (US20020051482A1-20020502-M00057.png)
FR (1) FR2413910A1 (US20020051482A1-20020502-M00057.png)
GB (1) GB2012161A (US20020051482A1-20020502-M00057.png)
IT (1) IT1117201B (US20020051482A1-20020502-M00057.png)
ZA (1) ZA787217B (US20020051482A1-20020502-M00057.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2612777A1 (fr) * 1987-03-26 1988-09-30 Inst Nat Sante Rech Med Composition medicamenteuse pour le traitement et la prevention de maladies dues a une cytotoxicite a mediation cellulaire, renfermant au moins un derive de la pyridine comme principe actif
US5562277A (en) * 1994-09-02 1996-10-08 Chick Machine Tool, Inc. Modular vise-like workholding system
WO1996026675A1 (en) * 1995-02-28 1996-09-06 Boston Scientific Corporation Deflectable catheter for ablating cardiac tissue
US6043368A (en) * 1996-09-04 2000-03-28 Poli Industria Chimica, S.P.A. Method of making thieno-pyridine derivatives
FR2818547B1 (fr) * 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation
CN1988934B (zh) * 2004-05-28 2011-01-05 奥坦纳医药公司 四氢吡啶并噻吩化合物
EP1756118B1 (en) * 2004-06-04 2008-05-28 Nycomed GmbH Tetrahydropyridothiophenes for use in the treatment of cancer
EP1758655A2 (en) * 2004-06-11 2007-03-07 Altana Pharma AG Tetrahydropyridothiophenes for treating hyperproliferative disorders
CA2596202A1 (en) * 2005-02-09 2006-08-17 Altana Pharma Ag Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
US20090252706A1 (en) * 2005-02-11 2009-10-08 Klaus Pekari Tetrahydropyridothiophenes As Antripoliferative Agents For The Treatment Of Cancer
WO2006084904A1 (en) * 2005-02-11 2006-08-17 Nycomed Gmbh Tetrahydropyridothiophenes as antripoliferative agents for the treatment of cancer
EP1896484A2 (en) * 2005-05-25 2008-03-12 Nycomed GmbH Tetrahydropyridothiophenes for use in the treatment of cancer
JP2008542243A (ja) * 2005-05-25 2008-11-27 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規のテトラヒドロピリドチオフェン
WO2014087240A2 (en) * 2012-12-04 2014-06-12 Dalhousie University Compositions, methods and kits for preventing, reducing, and eliminating cancer metastasis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948B1 (US20020051482A1-20020502-M00057.png) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma

Also Published As

Publication number Publication date
GB2012161A (en) 1979-07-25
IT1117201B (it) 1986-02-17
JPS6153325B2 (US20020051482A1-20020502-M00057.png) 1986-11-17
AU4316879A (en) 1979-07-12
US4963559A (en) 1990-10-16
BE873326A (fr) 1979-07-05
FR2413910A1 (fr) 1979-08-03
ZA787217B (en) 1979-12-27
FR2413910B1 (US20020051482A1-20020502-M00057.png) 1980-10-24
IT7947524A0 (it) 1979-01-04
DE2900203A1 (de) 1979-07-12
AU519516B2 (en) 1981-12-10

Similar Documents

Publication Publication Date Title
JPS5498337A (en) Anticarcinogenic and/or antimetastatic agent
FI880720A0 (fi) Foerfarande foer framstaellning av en hoegervridande enantiomer av metyl-alfa-5-(4,5,6,7-tetrahydro (3,2-c) tienopyridyl)-(2-klorfenyl) acetat.
SE8402551L (sv) Cinnamoylmoranolin-derivat
JPS5412372A (en) Thiazolidine derivative and its preparation
NO155665C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,7,7a-tetrahydro-4h-thieno-(3,2-c)-pyridin-2-on-derivater.
IT7829910A0 (it) Derivati dell'acido fosfonoso, procedimenti per la loro preparazione e loro impiego per combattere microorganismi.
JPS52106836A (en) N-trichloroacetyl-n#-chlorobenzoylhydrazine derivatives and germicide s for agriculture and horticulture containing thereof
JPS5350316A (en) Drug composition for oral administration
ES8308317A1 (es) Procedimiento de preparacion de nuevos derivados de 2-fenilmorfolina.
JPS542337A (en) Bactericidal composition for medical use
JPS5770806A (en) Fungicide composition
JPS54105236A (en) Antithrombogenetic agent for shunt and/or artificial blood vessel
JPS646214A (en) Remedy for ulcerative colonopathy
JPS545953A (en) Prostaglandin analogous compounds, process for their preparation and pharmaceutical composition containing the same as active constituents
JPS5344591A (en) Preparation of adenine derivatives
JPS5420141A (en) Method and composition for preventing gastro-intestinal diseases of cattle
JPS52108013A (en) Artificial saliva
JPS53127832A (en) Antiphkogistics for oral administration containing thiaprostaglandins
JPS54126737A (en) Antithrombotic agent
JPS52136923A (en) Method of combatting pancreatic necrosis of fishes
JPS5486626A (en) Remedy for peripheral artery obstruction
IE45193L (en) Amoxycillin composition
JPS54122737A (en) Remedy for pericementosis
JPS5283515A (en) N-dimethyl-1- (l-(-)-alpha-hydroxy-omega-aminoalkanoyl) -xk-62-2
JPS5498339A (en) Carcinostatic agent